ETHICON SUTURE LABORATORIES INCORPORATED – Trademark Portfolio
Entity Type: 03
ETHICON SUTURE LABORATORIES INCORPORATED holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ETHICON, LIGAPAK, and SUTUPAK. The owner is based in NEW BRUNSWICK, NJ.
501 GEORGE STREET
NEW BRUNSWICK, NJ
Showing of trademarks Trademarks
Trademark Classifications
ETHICON SUTURE LABORATORIES INCORPORATED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ETHICON SUTURE LABORATORIES INCORPORATED have?
ETHICON SUTURE LABORATORIES INCORPORATED has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 cancelled.
What trademark classes does ETHICON SUTURE LABORATORIES INCORPORATED file in?
ETHICON SUTURE LABORATORIES INCORPORATED files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 14 (Jewelry). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ETHICON SUTURE LABORATORIES INCORPORATED's most well-known trademarks?
ETHICON SUTURE LABORATORIES INCORPORATED's registered trademark portfolio includes well-known marks such as ETHICON, LIGAPAK, and SUTUPAK. These are among 3 currently registered trademarks in the portfolio.
What is ETHICON SUTURE LABORATORIES INCORPORATED's trademark registration success rate?
ETHICON SUTURE LABORATORIES INCORPORATED has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.